Clinical trial for Lung Cancer Screening
Official title Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
ClinicalTrials.gov ID: NCT07576595
What this study is testing
- What it's testing
- The study wants to see if a combined screening and quit‑smoking program can lower lung cancer risk and address health disparities in African American smokers.
- Who it's for
- African American adults who currently smoke cigarettes.
- What's involved
- Participants will receive low‑dose CT scans for lung cancer screening and counseling or resources to help them stop smoking.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- African American
- 20+ pack years of smoking
- eligible for or received LDCT screening
- current smoker
- English speaking
The study team makes the final eligibility decision.
Where it is enrolling
- New Orleans, Louisiana, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New Orleans, Louisiana, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.